+86-474-4860105

What is the role of Povidone 90 in the formation of liposomes?

Apr 14, 2026

William Rodriguez
William Rodriguez
William is an industry evaluator who has closely followed the development of Ulanqab Kema New Material Co., Ltd. He has given positive evaluations of the company's production capacity, product quality, and development potential in the new material field.

Povidone 90, also known as Polyvinylpyrrolidone (PVP) with a specific molecular weight characteristic, has been attracting significant attention in the field of liposome formation. As a leading supplier of Povidone 90, I am excited to explore the multifaceted role that this remarkable polymer plays in the creation and functionality of liposomes.

Basics of Liposomes

Liposomes are spherical vesicles composed of one or more phospholipid bilayers enclosing an aqueous core. They have been widely used in various fields such as drug delivery, cosmetics, and food science due to their ability to encapsulate both hydrophilic and hydrophobic substances, biocompatibility, and potential for controlled release. However, the formation and stability of liposomes can be influenced by many factors, and the addition of polymers like Povidone K90 can have a profound impact.

Solubility and Dispersion Enhancement

One of the primary roles of Povidone K90 in liposome formation is enhancing the solubility and dispersion of the components involved. Phospholipids, which are the building blocks of liposomes, may have limited solubility in certain solvents. Povidone 90 acts as a solubilizing agent, helping the phospholipids to disperse more uniformly in the solvent phase. This improved dispersion is crucial as it ensures a more homogeneous distribution of the phospholipids during the liposome formation process.

When phospholipids are better dispersed, they can more readily assemble into the characteristic bilayer structure of liposomes. The hydrophilic part of Povidone K90 interacts with the aqueous environment, while its hydrophobic regions can interact with the non - polar parts of the phospholipids. This dual - nature interaction promotes a more ordered arrangement of phospholipids, leading to the formation of well - defined liposomes. For example, in the preparation of liposomes for drug delivery, the use of Povidone K90 can help dissolve lipophilic drugs along with the phospholipids, allowing for efficient encapsulation within the liposomal structure.

Polyvinylpyrrolidone PVP is a well - known polymer in the industry, and Povidone K90 is a high - molecular - weight variant that offers enhanced solubility and dispersion properties compared to lower - molecular - weight counterparts. This makes it particularly suitable for applications where a high degree of component dispersion is required.

Stabilization of Liposome Structure

The stability of liposomes is a critical factor in their practical applications. Liposomes can be prone to aggregation, fusion, and leakage of encapsulated substances over time. Povidone K90 can act as a stabilizing agent for liposomes. It forms a protective layer around the liposome surface, reducing the tendency of liposomes to aggregate.

Polyvinylpyrrolidone PvpVinylpyrrolidone Polymer

The high molecular weight of Povidone K90 creates a steric hindrance effect. This means that the polymer chains extend into the surrounding medium, preventing liposomes from coming into close contact with each other and thus reducing the likelihood of aggregation. Additionally, the interaction between Povidone K90 and the liposome surface can strengthen the bilayer structure, making it more resistant to deformation and rupture.

For instance, in cosmetic formulations containing liposomes, the use of Povidone 90 can help maintain the integrity of the liposomes during storage and application. This ensures that the encapsulated active ingredients, such as vitamins or antioxidants, remain protected and are released in a controlled manner when the liposomes reach the target site on the skin.

Control of Liposome Size

The size of liposomes is an important parameter that affects their biological fate and functionality. Smaller liposomes, for example, may have better penetration into cells and tissues, while larger liposomes can have longer circulation times in the bloodstream. Povidone K90 can play a role in controlling the size of liposomes during their formation.

The concentration of Povidone K90 in the liposome preparation can influence the size distribution. Higher concentrations of Povidone K90 can lead to the formation of smaller liposomes. This is because the polymer can interact with the phospholipids during the self - assembly process and restrict the growth of the liposomal structures. By adjusting the amount of Povidone K90 added, it is possible to achieve a desired liposome size range for specific applications.

Polyvinylpyrrolidone K25 is a lower - molecular - weight form of PVP. In comparison, Povidone K90's higher molecular weight gives it a greater ability to influence liposome size due to its more extensive interaction with the phospholipid molecules and the formation of a more substantial polymer network during liposome formation.

Interaction with Encapsulated Substances

Povidone K90 can also have an impact on the substances encapsulated within the liposomes. It may interact with the encapsulated drugs, nutrients, or other active ingredients in a way that affects their release profile.

For hydrophilic drugs, Povidone 90 can form a complex with the drug molecules in the aqueous core of the liposome. This complexation can slow down the release of the drug from the liposome, providing a more controlled release effect. In the case of hydrophobic drugs, Povidone 90 can help solubilize the drug within the liposomal bilayer and also influence its diffusion out of the liposome.

In food applications, when liposomes are used to encapsulate flavors or bioactive compounds, Povidone 90 can enhance the stability of these encapsulated substances and control their release during food processing and consumption.

Compatibility and Biocompatibility

Povidone K90 is known for its excellent compatibility with a wide range of substances used in liposome formation, including phospholipids, drugs, and other additives. It is also highly biocompatible, which is a crucial property for applications in the pharmaceutical and cosmetic industries.

The biocompatibility of Povidone K90 ensures that the liposomes containing it are well - tolerated by biological systems. When used in drug delivery, liposomes with Povidone K90 are less likely to cause adverse immune responses or toxicity. This makes them a safe and effective option for delivering therapeutic agents to the body.

Vinylpyrrolidone Polymer is a general term for polymers related to Povidone. Povidone K90, as a specific member of this family, offers unique properties in terms of its compatibility and biocompatibility, making it a valuable component in liposome - based formulations.

Conclusion and Call to Action

In conclusion, Povidone K90 plays a vital role in the formation of liposomes, including enhancing solubility and dispersion, stabilizing the liposome structure, controlling liposome size, influencing the release of encapsulated substances, and providing excellent compatibility and biocompatibility. As a supplier of high - quality Povidone K90, I understand the importance of these properties in various applications.

If you are involved in research or production related to liposomes and are looking for a reliable Povidone K90 supplier, I encourage you to reach out to us for more information. We can provide you with samples to test the performance of our Povidone K90 in your specific liposome formulations. Together, we can explore the potential of Povidone K90 in enhancing the quality and functionality of your liposome - based products.

References

  1. Gregoriadis, G. (Ed.). (2012). Liposomes as Drug Carriers: Recent Trends and Progress. John Wiley & Sons.
  2. Torchilin, V. P. (2005). Recent advances with liposomes as pharmaceutical carriers. Nature Reviews Drug Discovery, 4(2), 145 - 160.
  3. Kabanov, A. V., & Alakhov, V. Y. (1998). Polymeric micelles as new drug carriers. Current Opinion in Colloid & Interface Science, 3(6), 692 - 700.

Send Inquiry